Literature DB >> 15621871

Indocyanine green angiography in ocular tuberculosis.

Evren Tayanc1, Yonca Akova, Gürsel Yilmaz.   

Abstract

PURPOSE: To assess indocyanine green (ICG) angiography as a method for evaluating the extent of choroidal involvement and to compare ICG angiography with fundus fluorescein angiography (FFA) in ocular tuberculosis.
METHODS: FFA and ICG angiography were performed on two patients who had ocular tuberculosis findings during fundus examination. The patients were given topical dexamethasone phosphate, topical cyclopentolate, and oral prednisolone acetate in addition to systemic antimicrobial therapy. Both examinations were repeated after treatment.
RESULTS: In one patient, two hypofluorescent lesions that corresponded to the choroidal tuberculomas were noted with ICG angiography. Only one lesion was found during ophthalmoscopic examination and FFA. After treatment, these lesions persisted, but became less hypofluorescent. In the other patient, ICG angiography showed a hypofluorescent choroidal lesion corresponding to the choroidal tuberculoma that was larger than its appearance on FFA. This lesion remained hypofluorescent in all phases of ICG angiography and became less hypofluorescent after treatment.
CONCLUSIONS: ICG angiography is a useful method to determine the extent of the choroidal lesion and the stage of disease and to evaluate treatment results in tuberculosis patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15621871     DOI: 10.1080/092739490500336

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  2 in total

1.  Bilateral choroidal tuberculoma in miliary tuberculosis - report of a case.

Authors:  Radha Annamalai; Jyotirmay Biswas
Journal:  J Ophthalmic Inflamm Infect       Date:  2015-02-13

2.  Contribution of Dual Fluorescein and Indocyanine Green Angiography to the Appraisal of Presumed Tuberculous Chorioretinitis in a Non-endemic Area.

Authors:  Raphael Massy; Carl P Herbort
Journal:  J Ophthalmic Vis Res       Date:  2017 Jan-Mar
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.